• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LYU Jiahui, JIANG Minmin, SHI Hui, LI Jianyuan, DU Zhenning. Effects and mechanism of peroxiredoxin-6 on ultraviolet-induced corneal injury in rats[J]. Journal of China Pharmaceutical University, 2016, 47(1): 84-89. DOI: 10.11665/j.issn.1000-5048.20160112
Citation: LYU Jiahui, JIANG Minmin, SHI Hui, LI Jianyuan, DU Zhenning. Effects and mechanism of peroxiredoxin-6 on ultraviolet-induced corneal injury in rats[J]. Journal of China Pharmaceutical University, 2016, 47(1): 84-89. DOI: 10.11665/j.issn.1000-5048.20160112

Effects and mechanism of peroxiredoxin-6 on ultraviolet-induced corneal injury in rats

More Information
  • To investigate the therapeutic effect of peroxiredoxin-6(PRDX6)on ultraviolet-induced corneal injury in rats and explore the mechanism, a rat model of corneal injury was established by exposing to ultraviolet. Male Wister rats were randomly divided into control group, dexamethasone(DXM)group and PRDX6 group. All the rats were administered four times a day and for 12 days. The corneal opacity was observed with a slit-lamp microscope. Histopathologic changes were observed with light microscope. The content of corneal malonaldehyde(MDA)was determined by thiobarbituric acid test; the total antioxidative capacity(TAOC)was detected by chemical colorimetric test. P38 MAPK signaling pathway was detected with the method of Western blot and gene expression of cytokines was measured by RT-PCR. Compared with the control group, PRDX6 treatment significantly reduced corneal opacity, improved corneal pathology injury, decreased the MDA content and increased the TAOC. In the PRDX6 group, the level of phosphorylated p38 protein was significantly lower than that in the control group. The gene expression of cytokine was different between the control and PRDX6 groups(P < 0. 05). PRDX6 showed therapeutic effect in the rat model of ultraviolet-induced corneal injury, which may be because it could alleviate the oxidative damage, suppress p38 MAPK phosphorylation and regulate the gene expression of cytokine.
  • [1]
    Youn HY, McCanna DJ, Sivak JG, et al. In vitro ultraviolet-induced damage in human corneal,lens,and retinal pigment epithelial cells[J].Mol Vis,2011,17(3):237-246.
    [2]
    Chandler HL,Reuter KS,Sinnott LT,et al.Prevention of UV-induced damage to the anterior segment using class I UV-absorbing hydrogel contact lenses[J].Invest Ophthalmol Vis Sci,2010,51(1):172-178.
    [3]
    Rubowitz A,Assia EI,Rosner M,et al.Antioxidant protection against corneal damage by free radicals during phacoemulsification[J].Invest Ophthalmol Vis Sci,2003,44(5):1866-1870.
    [4]
    Shi H,Yu HJ,Wang HY,et al.Topical Administration of Peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation[J].Invest Ophthalmol Vis Sci,2012,53(13):8016-8028.
    [5]
    Cui Y,Wu J,Zong M,et al.Proteomic profiling in pancreatic cancer with and without lymph node metastasis[J].Int J Cancer,2009,124(7):1614-1621.
    [6]
    Dickey JB,Cassidy EM,Bouchard CS.Periocular FK-506 delays allograft rejection in rat penetrating keratoplasty[J].Cornea,1993,12(3):204-207.
    [7]
    Erol B,Bozlu M,Hanci V,et al.Coenzyme Q10 treatment reduces lipid peroxidation inducible and endothelial nitric oxide synthases,and germ cell-specific apoptosis in a rat model of testicular ischemia/reperfusion injury[J].Fertil Steril,2010,93(1):280-282.
    [8]
    Suh MH,Kwon JW,Wee WR,et al.Protective effect of ascorbic acid against corneal damage by ultraviolet B irradiation:a pilot study[J].Cornea,2008,27(8):916-922.
    [9]
    Hollyfield JG,Bonilha VL,Rayborn ME,et al.Oxidative damage induced inflammation initiates age-related macular degeneration[J].Nat Med,2008,14(2):194-198.
    [10]
    Yang D, Song Y, Wang X, et al. Deletion of peroxinredoxin 6 potentiates lipopolysaccharide-induced acute lung injury in mice[J].Crit Care Med,2011,39(4):756-764.
    [11]
    Li J,Liu F,Wang H,et al.Systematic mapping and functional analysis of a family of human epididymal secretory sperm-located proteins[J].Mol Cell Proteomics,2010,9(11):2517-2528.
    [12]
    Wu F,Lee S,Schumacher M,et al.Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon[J].Exp Eye Res,2008,87(3):214-225.
    [13]
    Kubo E,Miyazawa T,Fatma N,et al.Development- and age-associated expression pattern of peroxiredoxin 6,and its regulation in murine ocular lens[J].Mech Ageing Dev,2006,127(3):249-256.
    [14]
    Schieven GL.The biology of p38 kinase:a central role ininflammation[J].Curr Top Med Chem,2005,5(10):921-928.
  • Cited by

    Periodical cited type(14)

    1. 王经纬,陈晓颙,袁怡,刘晨曦,胡敏. 阿达帕林凝胶原研药与仿制药的流变学特性一致性考察. 药学前沿. 2025(01): 33-39 .
    2. 方泽卿,罗华菲,朱慧勇,黄贺敏. 药用辅料用压敏胶流变学的研究进展. 中国医药工业杂志. 2025(03): 303-314 .
    3. 欧阳艺,陈昌蓉,江宇凯. 复合黄酮乳膏的流变学特性. 广东化工. 2025(07): 44-46+20 .
    4. 白明月,杨俊,胡秀云,臧可昕,米楠. 触变胶型口服混悬液的流变学测定样品处理方法研究与盐酸鲁拉西酮口服混悬液流变学特征评价. 药物评价研究. 2025(06): 1587-1595 .
    5. 刘超逸,高旋,王林波,陈晓萍,秦峰,吴晓鸾. 2类皮肤外用半固体制剂屈服应力测定方法的研究. 中国新药杂志. 2024(14): 1489-1495 .
    6. 荣娜娜,朱嘉亮,刘继华,王莹,吴静. HPLC法测定丁酸氢化可的松乳膏中有关物质. 大理大学学报. 2024(08): 46-52 .
    7. 陈倩倩,刘正平,李硕蕾,薛松,李大伟. 盐酸特比萘芬乳膏流变学性质的研究. 中国药师. 2024(08): 1296-1302 .
    8. 王丽丽,祝美华,陈建英. 软膏基质白凡士林的流变学性质研究. 食品与药品. 2024(06): 584-589 .
    9. 钱喜龙,王可为,刘政,周柳,马瑜璐,房方,章阳,王业皇,江滨,刘圣金. 基于确定性筛选设计优化榆皇生肌乳膏的制备工艺. 中国新药杂志. 2024(23): 2518-2528 .
    10. 刘晓纯,罗婷婷,戴洁,陈来成,何秋星. 美藤果发酵多肽对液晶乳液结构的影响(英文). 日用化学工业(中英文). 2024(12): 1456-1464 .
    11. 杨凯丽,郭子硕,张翼,陈宛灵,王晓静,杜守颖,李鹏跃. 甘草酸凝胶的流变学性质及其对橙皮苷的增溶作用研究. 中草药. 2023(11): 3468-3479 .
    12. 方媛,刘子修,冯明庆,吴鹏,王培民,茆军. 三色散凝胶贴膏处方优化. 中成药. 2023(11): 3718-3723 .
    13. 郑荣蕾,杨放,刘睿鹏,张梅,田佩灵,刘涛. 喷膜剂成型过程及质量控制关键技术探讨. 成都大学学报(自然科学版). 2022(03): 225-229 .
    14. 李娇,刘变娥,高雪锋,秦敦忠,张宇,寇俊杰. 吡唑醚菌酯悬浮剂流变性与稳定性的关系研究. 现代农药. 2022(06): 19-27 .

    Other cited types(5)

Catalog

    Article views (1139) PDF downloads (1793) Cited by(19)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return